Advanced search
Add to list

Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051)

(2009) JOURNAL OF THORACIC ONCOLOGY. 4(9). p.S791-S791
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Van Meerbeeck, Jan et al. “Pemetrexed (P) and Cisplatin (C) as Either Induction (IC) or Adjuvant (AC) Chemotherapy in Stage IB-II Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase 2 Study (EORTC 08051).” Journal of Thoracic Oncology. Vol. 4. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2009. S791–S791. Print.
APA
Van Meerbeeck, J., Germonpre, P., Vermassen, F., Welch, J., & Van Schil, P. (2009). Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051). JOURNAL OF THORACIC ONCOLOGY (Vol. 4, pp. S791–S791). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Chicago author-date
Van Meerbeeck, Jan, P Germonpre, Frank Vermassen, J Welch, and PE Van Schil. 2009. “Pemetrexed (P) and Cisplatin (C) as Either Induction (IC) or Adjuvant (AC) Chemotherapy in Stage IB-II Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase 2 Study (EORTC 08051).” In Journal of Thoracic Oncology, 4:S791–S791. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Chicago author-date (all authors)
Van Meerbeeck, Jan, P Germonpre, Frank Vermassen, J Welch, and PE Van Schil. 2009. “Pemetrexed (P) and Cisplatin (C) as Either Induction (IC) or Adjuvant (AC) Chemotherapy in Stage IB-II Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase 2 Study (EORTC 08051).” In Journal of Thoracic Oncology, 4:S791–S791. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Vancouver
1.
Van Meerbeeck J, Germonpre P, Vermassen F, Welch J, Van Schil P. Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051). JOURNAL OF THORACIC ONCOLOGY. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S791–S791.
IEEE
[1]
J. Van Meerbeeck, P. Germonpre, F. Vermassen, J. Welch, and P. Van Schil, “Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051),” in JOURNAL OF THORACIC ONCOLOGY, 2009, vol. 4, no. 9, pp. S791–S791.
@inproceedings{861656,
  author       = {Van Meerbeeck, Jan and Germonpre, P and Vermassen, Frank and Welch, J and Van Schil, PE},
  booktitle    = {JOURNAL OF THORACIC ONCOLOGY},
  issn         = {1556-0864},
  language     = {eng},
  number       = {9},
  pages        = {S791--S791},
  publisher    = {LIPPINCOTT WILLIAMS & WILKINS},
  title        = {Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051)},
  volume       = {4},
  year         = {2009},
}

Web of Science
Times cited: